Literature DB >> 9733853

Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis.

C Tober1, M Seufert, H Schneider, M A Billeter, I C Johnston, S Niewiesk, V ter Meulen, S Schneider-Schaulies.   

Abstract

Nonstructural proteins encoded by measles virus (MV) include the V protein which is translated from an edited P mRNA. V protein is not associated with intracellular or released viral particles and has recently been found to be dispensable for MV propagation in cell culture (H. Schneider, K. Kaelin, and M. A. Billeter, Virology 227:314-322, 1997). Using recombinant MVs (strain Edmonston [ED]) genetically engineered to overexpress V protein (ED-V+) or to be deficient for V protein (ED-V-), we found that in the absence of V both MV-specific proteins and RNAs accumulated to levels higher than those in the parental MV molecular clone (ED-tag), whereas MV-specific gene expression was strongly attenuated in human U-87 glioblastomas cells after infection with ED-V+. The titers of virus released from these cells 48 h after infection with either V mutant virus were lower than those from cells infected with ED-tag. Similarly, significantly reduced titers of infectious virus were reisolated from lung tissue of cotton rats (Sigmodon hispidus) after intranasal infection with both editing mutants compared to titers isolated from ED-tag-infected animals. In cell culture, expression of V protein led to a redistribution of MV N protein in doubly transfected Cos-7 cells, indicating that these proteins form heterologous complexes. This interaction was further confirmed by using a two-hybrid approach with both proteins expressed as Gal4 or VP16 fusion products. Moreover, V protein efficiently competed complexes formed between MV N and P proteins. These findings indicate that V protein acts to balance accumulation of viral gene products in cell culture, and this may be dependent on its interaction with MV N protein. Furthermore, expression of V protein may contribute to viral pathogenicity in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733853      PMCID: PMC110150          DOI: 10.1128/JVI.72.10.8124-8132.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Measles virus gene expression in neural cells.

Authors:  S Schneider-Schaulies; J Schneider-Schaulies; L M Dunster; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

2.  Measles virus V protein binds zinc.

Authors:  P Liston; D J Briedis
Journal:  Virology       Date:  1994-01       Impact factor: 3.616

3.  Hypermutation of the phosphoprotein and altered mRNA editing in the hamster neurotropic strain of measles virus.

Authors:  J A Vanchiere; W J Bellini; S A Moyer
Journal:  Virology       Date:  1995-03-10       Impact factor: 3.616

4.  In vivo interaction of rabies virus phosphoprotein (P) and nucleoprotein (N): existence of two N-binding sites on P protein.

Authors:  M Chenik; K Chebli; Y Gaudin; D Blondel
Journal:  J Gen Virol       Date:  1994-11       Impact factor: 3.891

5.  Ribosomal frameshifting during translation of measles virus P protein mRNA is capable of directing synthesis of a unique protein.

Authors:  P Liston; D J Briedis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites.

Authors:  T Das; A Schuster; S Schneider-Schaulies; A K Banerjee
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

7.  Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system.

Authors:  A M Takacs; T Das; A K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm.

Authors:  M Huber; R Cattaneo; P Spielhofer; C Orvell; E Norrby; M Messerli; J C Perriard; M A Billeter
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

9.  Expression and properties of the V protein in acute measles virus and subacute sclerosing panencephalitis virus strains.

Authors:  A F Gombart; A Hirano; T C Wong
Journal:  Virus Res       Date:  1992-09-01       Impact factor: 3.303

10.  The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing.

Authors:  J Curran; R Boeck; D Kolakofsky
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  45 in total

1.  Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.

Authors:  H Jin; X Cheng; H Z Zhou; S Li; A Seddiqui
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation.

Authors:  Shengwei Zhang; Longyun Chen; Guangyuan Zhang; Qin Yan; Xiaodan Yang; Binbin Ding; Qiaopeng Tang; Shengjun Sun; Zhulong Hu; Mingzhou Chen
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 6.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

7.  A highly attenuated measles virus vaccine strain encodes a fully functional C protein.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

8.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

10.  Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X protein.

Authors:  Urs Schneider; Melanie Naegele; Peter Staeheli; Martin Schwemmle
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.